PIPELINE
 |
| |
 |
| |
 |
| |
 |
| |
 |
Our primary development activities are focused around oral
route. Our current product portfolio consists of products
in Gastro Intestinal (GI), Cardiovascular (CV), Anti-viral
(HIV), Anti-bacterials and Central Nervous System (CNS)
area. Primarily, we focus on solid and liquid dosage forms.
However, our in-house work has resulted into a notable
work in other dosage form.
We have applied for a unique patent to deliver leukotriene
antagonist and similar class of compounds via Intra-nasal
delivery. We have observed significant clinical benefits
with patients of all ages, genders and ethnic diversity. We
are exploring partnership for this opportunity.
copyright Patrin Pharma 2005-2011
route. Our current product portfolio consists of products
in Gastro Intestinal (GI), Cardiovascular (CV), Anti-viral
(HIV), Anti-bacterials and Central Nervous System (CNS)
area. Primarily, we focus on solid and liquid dosage forms.
However, our in-house work has resulted into a notable
work in other dosage form.
We have applied for a unique patent to deliver leukotriene
antagonist and similar class of compounds via Intra-nasal
delivery. We have observed significant clinical benefits
with patients of all ages, genders and ethnic diversity. We
are exploring partnership for this opportunity.
copyright Patrin Pharma 2005-2011
